 It is non-essential & glucogenic amino acid.
 Cysteine is present in large quantity in
keratin of hair & nails.
 Formation of cysteine is by using the carbon
skeleton contributed by serine & sulfur
originating from methionine.
 Homocysteine formed from methionine is a
precursor for the synthesis of cysteine.
 Homocysteine condenses with serine to form
cystathionine.
 This reaction is catalysed by a PLP-
dependent cystathionine synthase.
 The enzyme cystathioninase (PLP-dependent)
cleaves & deaminates cystathionine to
cysteine & α-ketobutyrate.
Methionine
Homocysteine
Cystathionine
Cysteineα-ketobutyrate
Serine
H2O
Cystathionine β-synthase
Succinyl CoA
γ-Cystathioninase
Homocysteinemia
type-1
Cysteine formation
 Homocysteine is an intermediate in the synthesis of
cysteine from methionine.
 Elevation in plasma homocysteine (normal <15 pmol/l)
has been implicated in coronary artery disease.
 Homocysteine reacts with collagen to produce
reactive free radicals, besides interfering with
collagen cross links.
 Homocysteine is also involved in the aggregation of
LDL particle & leads to atherosclerosis.
 Cystine & cysteine are interconvertible by an
NAD+ dependent cystine reductase.
 Cysteine on decarboxylation produces
mercaptoethanolamine which is involved in
the biosynthesis of coenzyme A from the
vitamin pantothenic acid.
Decarboxylation Cysteine
Decarboxylase, PLP
 The enzyme cysteine dioxygenase oxidizes
cysteine to cysteine sulfinate, on further
oxidation, is converted to cysteic acid.
 Cysteic acid undergoes decarboxylation to
produce taurine which conjugates with bile
acids.
 Cysteic acid can also be degraded to
pyruvate, which is glycogenic.
Formation of taurine from cysteine
1. Cysteine dioxygenase, 2. Decarboxylase
 Cysteine sulfinate cleaves off alanine to
produce sulfite which is converted to sulfate
& excreted in urine.
 Some amount of sulfate condenses with ATP
to form active sulfate or 3'-
phosphoadenosine 5'-phosphosulfafe (PAPS).
 Active sulfate (PAPS) is utilized for the
synthesis of mucopolysaccharides.
 Used in detoxification.
 Sulfate is also a structural component of
proteins & lipids.
 Cysteine can be degraded by desulfhydrase to
liberate sulfur (as H2S), ammonia & pyruvate.
 Cysteine is a component of glutathione.
PAPS
 Cysteine is required for formation of
Glutathione.
 Glutathionine is required for transport of
amino acids.
 Glutathione is present in the RBCs.
 This is used for inactivation of free radicals
formed inside RBC.
 Glutathione helps to detoxify several
compounds.
 Glutathione keeps the enzymes in reduced,
active state.
 Cysteine residues in polypeptide chains form
disulfide bridges to make active proteins,
e.g. insulin & immunoglobulins.
 Cystinuria (cystine-lysinuria):
 The most common inherited disease.
 It is characterized by increased excretion of
cystine (25-40 times normal).
 Elevation in the urinary output of lysine,
arginine & ornithine is also observed.
 A specific carrier system exists in kidney
tubules for the reabsorption of amino acids,
namely cysteine, ornithine, arginine & lysine
(COAL to recall).
 In cystinuria, this carrier system becomes
defective leading to the excretion of all these
four amino acids in urine.
 Cystine is relatively insoluble & increased
concentrations leads to precipitation &
formation of cystine stones in kidney & urinary
tract.
 Cystinuria is usually identified in the
laboratory by cyanide nitroprusside test.
 The treatment includes restricted ingestion of
dietary cystine & high intake of fluids.
 Cystine crystals are deposited in many tissues
& organs of reticuloendothelial system
throughout the body.
 These include spleen, lymph nodes, liver,
kidney, bone marrow etc.
 A defect in the Iysosomal function.
 Cystine accumulates in the lysosomes of
various tissues.
 In cystinosis, renal function is impaired.
 It is characterized by generalized amino
aciduria.
 The affected patients die within 10 years,
mostly due to renal failure.
 It is also due to defect in the enzyme cystine
reductase (interconverting enzyme).
 Homocystinurias are a group of metabolic
disorders characterized by the accumulation
& increased urinary excretion of
homocysteine & S-adenosylmethionine (SAM).
 Plasma concentration of methionine is
increased.
 Enzyme defect: Cystathionine synthase.
 Accumulation of homocystetne.
 It results in various complications-thrombosis,
osteoporosis & mental retardation.
 The deficiency of cystathionine is associated
with damage to endothelial cells which might
lead to atherosclerosis.
 Two forms of type I homocystinurias
 One of them can be corrected with vitamin B6
supplementation (B6 responsive) while the
other does not respond to B6.
 The treatment includes consumption of diet
low in methionine & high in cystine.
 The patients of homocystinuria have high
levels of homocysteine & usually die of
myocardial infarction, stroke.
 Homocystinuria ll:
 N5 - N10 - Methylene THF reductase.
 Homocystinuria lll:
 N5 - N10 - Methyl THF homocysteine methyltransferase.
 This is mostly due to impairment in the synthesis of
methylcobalamin.
 Homocystinurla lV:
 N5 - Methyl THF homocysteine methyl transferase.
 This is primarily due to a defect in the intestinal
absorption of vitamin B12.
 Textbook of Biochemistry - U Satyanarayana
 Textbook of Biochemistry - DM Vasudevan
CYSTEINE METABOLISM

CYSTEINE METABOLISM

  • 2.
     It isnon-essential & glucogenic amino acid.  Cysteine is present in large quantity in keratin of hair & nails.  Formation of cysteine is by using the carbon skeleton contributed by serine & sulfur originating from methionine.
  • 3.
     Homocysteine formedfrom methionine is a precursor for the synthesis of cysteine.  Homocysteine condenses with serine to form cystathionine.
  • 4.
     This reactionis catalysed by a PLP- dependent cystathionine synthase.  The enzyme cystathioninase (PLP-dependent) cleaves & deaminates cystathionine to cysteine & α-ketobutyrate.
  • 5.
  • 6.
  • 7.
     Homocysteine isan intermediate in the synthesis of cysteine from methionine.  Elevation in plasma homocysteine (normal <15 pmol/l) has been implicated in coronary artery disease.  Homocysteine reacts with collagen to produce reactive free radicals, besides interfering with collagen cross links.  Homocysteine is also involved in the aggregation of LDL particle & leads to atherosclerosis.
  • 8.
     Cystine &cysteine are interconvertible by an NAD+ dependent cystine reductase.  Cysteine on decarboxylation produces mercaptoethanolamine which is involved in the biosynthesis of coenzyme A from the vitamin pantothenic acid.
  • 9.
  • 10.
     The enzymecysteine dioxygenase oxidizes cysteine to cysteine sulfinate, on further oxidation, is converted to cysteic acid.  Cysteic acid undergoes decarboxylation to produce taurine which conjugates with bile acids.  Cysteic acid can also be degraded to pyruvate, which is glycogenic.
  • 11.
    Formation of taurinefrom cysteine 1. Cysteine dioxygenase, 2. Decarboxylase
  • 12.
     Cysteine sulfinatecleaves off alanine to produce sulfite which is converted to sulfate & excreted in urine.  Some amount of sulfate condenses with ATP to form active sulfate or 3'- phosphoadenosine 5'-phosphosulfafe (PAPS).
  • 13.
     Active sulfate(PAPS) is utilized for the synthesis of mucopolysaccharides.  Used in detoxification.  Sulfate is also a structural component of proteins & lipids.  Cysteine can be degraded by desulfhydrase to liberate sulfur (as H2S), ammonia & pyruvate.  Cysteine is a component of glutathione.
  • 14.
  • 15.
     Cysteine isrequired for formation of Glutathione.  Glutathionine is required for transport of amino acids.  Glutathione is present in the RBCs.  This is used for inactivation of free radicals formed inside RBC.
  • 16.
     Glutathione helpsto detoxify several compounds.  Glutathione keeps the enzymes in reduced, active state.  Cysteine residues in polypeptide chains form disulfide bridges to make active proteins, e.g. insulin & immunoglobulins.
  • 17.
     Cystinuria (cystine-lysinuria): The most common inherited disease.  It is characterized by increased excretion of cystine (25-40 times normal).  Elevation in the urinary output of lysine, arginine & ornithine is also observed.
  • 18.
     A specificcarrier system exists in kidney tubules for the reabsorption of amino acids, namely cysteine, ornithine, arginine & lysine (COAL to recall).  In cystinuria, this carrier system becomes defective leading to the excretion of all these four amino acids in urine.
  • 19.
     Cystine isrelatively insoluble & increased concentrations leads to precipitation & formation of cystine stones in kidney & urinary tract.  Cystinuria is usually identified in the laboratory by cyanide nitroprusside test.  The treatment includes restricted ingestion of dietary cystine & high intake of fluids.
  • 20.
     Cystine crystalsare deposited in many tissues & organs of reticuloendothelial system throughout the body.  These include spleen, lymph nodes, liver, kidney, bone marrow etc.  A defect in the Iysosomal function.  Cystine accumulates in the lysosomes of various tissues.
  • 21.
     In cystinosis,renal function is impaired.  It is characterized by generalized amino aciduria.  The affected patients die within 10 years, mostly due to renal failure.  It is also due to defect in the enzyme cystine reductase (interconverting enzyme).
  • 22.
     Homocystinurias area group of metabolic disorders characterized by the accumulation & increased urinary excretion of homocysteine & S-adenosylmethionine (SAM).  Plasma concentration of methionine is increased.
  • 23.
     Enzyme defect:Cystathionine synthase.  Accumulation of homocystetne.  It results in various complications-thrombosis, osteoporosis & mental retardation.  The deficiency of cystathionine is associated with damage to endothelial cells which might lead to atherosclerosis.
  • 24.
     Two formsof type I homocystinurias  One of them can be corrected with vitamin B6 supplementation (B6 responsive) while the other does not respond to B6.  The treatment includes consumption of diet low in methionine & high in cystine.  The patients of homocystinuria have high levels of homocysteine & usually die of myocardial infarction, stroke.
  • 25.
     Homocystinuria ll: N5 - N10 - Methylene THF reductase.  Homocystinuria lll:  N5 - N10 - Methyl THF homocysteine methyltransferase.  This is mostly due to impairment in the synthesis of methylcobalamin.  Homocystinurla lV:  N5 - Methyl THF homocysteine methyl transferase.  This is primarily due to a defect in the intestinal absorption of vitamin B12.
  • 26.
     Textbook ofBiochemistry - U Satyanarayana  Textbook of Biochemistry - DM Vasudevan